32 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PRO-ACTIVE S.R.L.

Manufacturer
🇮🇹 Italy

Pro-Eko Srl

Manufacturer
🇮🇹 Italy·3 Basic UDI-DIs·8 Devices

Pro Medicare S.r.l.

Manufacturer
🇮🇹 Italy

4 PRO s.r.l.

Manufacturer
🇮🇹 Italy

PRO DATA S.r.l.

Manufacturer
🇮🇹 Italy·1 Basic UDI-DI·1 Device

11.50/4RF - DEAMBULATORE 4 RUOTE

Device
EU MDR · Eu Md Class 1 ·VASSILLI S.R.L.·On the market

Formalina Neutra Tamponata 4%

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

DIFF STAIN QUICK KIT

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

MP@web

Device
EU MDR · Eu Md Class 1 ·PRO DATA S.r.l.·On the market

SOLUZIONE DI LUGOL

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

MAY-GRÜNWALD

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

GIEMSA

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

EMATOSSILINA SECONDO HARRIS

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

PAPANICOLAOU SOLUZIONE EA50

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

PAPANICOLAOU SOLUZIONE OG6

Device
EU IVDR · Eu Ivd Class A ·Pro-Eko Srl·On the market

X-FRAME DRF

Basic UDI-DI
EU MDR · Eu Md Class 2b ·ITALRAY s.r.l.·1 device

Platinium DR DF4 1540, Model Number TDF036U, UDI/GTIN 08031527015477, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).

FDA Enforcement
Class II ·Terminated·Sorin Group Italia SRL - CRF·October 4, 2017

INTENSIA Models: VR 124, DR 154, CRT-D 174 Product Usage: OVATIO VR 6250, OVATIO DR 6550, PARADYM VR 8250, PARADYM DR 8550, PARADYM RF VR 9250, PARADYM RF DR 9550, INTENSIA VR 124 and INTENSIA DR 154 are indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT). OVATIO CRT 6750, PARADYM CRT-D 8750, PARADYM SonR 8770, PARADYM RF CRT-D 9750, PARADYM RF SonR 9770 and INTENSIA CRT-D 174 are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening arrhythmias. The devices are also indicated for the reduction of heart failure symptoms in medically optimized NYHA Functional Class III and IV patients with left ventricular ejection fraction of 35% or less, and a QRS duration of 150 ms or longer.

FDA Enforcement
Class II ·Terminated·Sorin Group Italia SRL - CRF·May 24, 2017

OVATIO Models: VR 6250, DR 6550, CRT 6750. Product Usage: OVATIO VR 6250, OVATIO DR 6550, PARADYM VR 8250, PARADYM DR 8550, PARADYM RF VR 9250, PARADYM RF DR 9550, INTENSIA VR 124 and INTENSIA DR 154 are indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT). OVATIO CRT 6750, PARADYM CRT-D 8750, PARADYM SonR 8770, PARADYM RF CRT-D 9750, PARADYM RF SonR 9770 and INTENSIA CRT-D 174 are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening arrhythmias. The devices are also indicated for the reduction of heart failure symptoms in medically optimized NYHA Functional Class III and IV patients with left ventricular ejection fraction of 35% or less, and a QRS duration of 150 ms or longer.

FDA Enforcement
Class II ·Terminated·Sorin Group Italia SRL - CRF·May 24, 2017

Platinium VR DF4 1240, Model Number TDF035U, UDI/GTIN 08031527015460, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).

FDA Enforcement
Class II ·Terminated·Sorin Group Italia SRL - CRF·October 4, 2017